Human immunodeficiency virus type 1 capsid protein p24 conserved elements (HIV-1 p24 CE)

The HIV-1 Gag p24 conserved elements refer to specific, highly invariant regions within the p24 capsid protein that are critical for the virus's structural integrity and replication cycle (UniProt P04591). These elements are prioritized in therapeutic and prophylactic strategies because mutations within them often lead to a significant loss of viral fitness, making them ideal targets for broad-spectrum interventions (PubMed: 24109231). Biologically, the p24 protein forms the cone-shaped capsid that protects the viral RNA genome and plays essential roles in viral uncoating, nuclear import, and assembly. In the context of drug development, small molecules like capsid inhibitors (e.g., Lenacapavir) bind to these regions to disrupt the stability of the capsid, thereby blocking multiple stages of the viral life cycle (FDA: Sunlenca). Additionally, conserved element vaccines (e.g., HTI vaccine) aim to direct the immune system's T-cell response toward these vulnerable segments to prevent the emergence of escape mutants (PubMed: 28834385). Targeting these elements is a key strategy in managing HIV-1 infection and pursuing a functional cure.

Other names

HIV-1 p24Capsid protein p24CA proteinGag p24Conserved elements of HIV-1 Gag

Capsid inhibitors bind to the p24 subunits to interfere with the assembly and disassembly of the viral capsid, while conserved element vaccines induce T-cell responses targeting invariant viral epitopes to prevent immune escape.